Although the association between von Willebrand factor levels and the increased risk of venous thromboembolism among people with non-O blood types has consistently been noted, recent findings from genome-wide association studies suggest that ABO antigens may also have an impact through additional mechanisms [56]. Here, VWF is linked to venous thromboembolism.